Furthermore, Raa and colleagues demonstrated that CLL patients with SF3B1 mutations have a decreased expression of TP53 target genes after irradiation, highlighting the possible role of SF3B1 mutations in regulating responses to DNA damage [65]. This evidence concerns the gene SF3B1 and B-cell chronic lymphocytic leukemia.